Cabaletta Bio, Inc
Price
FilingsNewest: 8-K, Other eventsSep 14 →Insiders8 insiders bought $296,210 in 8 open-market buys. No sales.→HoldersJennison Associates 19.9%Bain Capital Life Sciences Investors 17.2%BlackRock 10.7%→Financing →PeersClosest companies: FATE, KYTX, TCRX→
From the filings
Figures
- Net income
- −$181.3Mlast 12 months
- Operating cash flow
- −$142.8Mlast 12 months
- Cash and equivalents
- $225.1Mat the last balance sheet
- Shares outstanding
- 100.5M shareson issue